JUSTICE STEPHEN BREYER

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1308338
                    [Title] => High court voids overall contribution limits
                    [Summary] => 
WASHINGTON — The Supreme Court struck down limits yesterday in federal law on the overall campaign contributions the biggest individual donors may make to candidates, political parties and political action committees.

                    [DatePublished] => 2014-04-03 03:13:03
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 1500180
                    [AuthorName] => Mark Sherman
                    [SectionName] => World
                    [SectionUrl] => world
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 791204
                    [Title] => High court throws out human gene patents
                    [Summary] => 
The Supreme Court on yesterday threw out a  lower court ruling allowing human genes to be patented, a topic of  enormous interest to cancer researchers, patients and drug makers.
                    [DatePublished] => 2012-03-27 06:05:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

        )

)

abtest

High court voids overall contribution limits

By Mark Sherman | April 3, 2014 - 3:13am

WASHINGTON — The Supreme Court struck down limits yesterday in federal law on the overall campaign contributions the biggest individual donors may make to candidates, political parties and political action...

World

High court throws out human gene patents

March 27, 2012 - 6:05am

The Supreme Court on yesterday threw out a lower court ruling allowing human genes to be patented, a topic of enormous interest to cancer researchers, patients and drug makers.